Program Scientific Program

Scientific Program

  • 14:55-16:25

    Committee Session 1 (K)

    2026 Obesity Guideline Update: Practical Approaches to Diagnosis and Treatment

    will be updated.
    14:55-15:10

    2026 Obesity Clinical Practice Guideline: Major Updates and Clinical Implications

    Seung Hee Kim (Inje Univ., Korea)

    15:10-15:25

    Clinical Diagnosis of Obesity: Current Criteria and Practical Approach

    Young Sang Lyu (Chosun Univ., Korea)

    15:25-15:40

    Assessment of Obesity Prior to Treatment

    Ji-Hee Ham (Wellbone Hosp., Korea)

    15:40-15:55

    Pharmacotherapy: Treatment Based on Weight Loss Goals and Obesity-Related Complications

    EonJu Jeon (Daegu Catholic Univ., Korea)

    15:55-16:10

    Redefining the Role of Surgical Treatment in the Era of GLP-1RA

    Sang-Yong Son (Ajou Univ., Korea)

    16:10-16:25

    Panel Discussion

    Wonsock Kim (Eulji Univ., Korea)

    Youn Huh (The Catholic Univ. of Korea, Korea)

  • 16:25-17:55

    Committee Session 2

    From Human Biology to Precision Obesity Care: Translational Bridges Across Bench, Cohort, and Clinic

    will be updated.
    16:25-16:50

    Multi-Omics Insights into Multi-Organ Metabolic Crosstalk

    Joon Ho Moon (Seoul Nat'l Univ., Korea)

    16:50-17:15

    Multiomic Approaches to Identify Pathogenic Mechanisms Driving MASLD-to-MASH Progression

    Joonyub Lee (The Catholic Univ. of Korea, Korea)

    17:15-17:40

    Obesity Heterogeneity and Population Transitions Across Generations: Toward Precision Cardiometabolic Risk Stratification in Korea

    Min-Jeong Shin (Korea Univ., Korea)

    17:40-17:55

    Panel Discussion

    Eun Roh (Seoul Nat'l Univ., Korea)

    Min Soo Kim (KIST, Korea)

  • 18:30-19:30

    Satellite Symposium 1

    will be updated.
    18:30-19:00

    19:00-19:30

  • 14:55-16:25

    Best Articles in JOMES

    will be updated.
    14:55-15:10

    15:10-15:25

    15:25-15:40

    15:40-15:55

    15:55-16:10

    16:10-16:25

  • 13:10-14:40

    Policy Session (K)

    will be updated.
    13:10-14:40

  • 14:55-16:25

    Symposium 1

    Precision Exercise Interventions Based on Lifespan Characteristics of Obesity
    will be updated.
    14:55-15:20

    Arterial Myocyte Pannexin 1 Channel Controls Vascular Reactivity in Diabetic Hyperglycemia

    Junyoung Hong (Kyonggi Univ., Korea)

    15:20-15:45

    Exercise, Meal Timing, and Glycemic Index: Implications for Substrate Metabolism and Appetite Regulation in Middle-Aged and Postmenopausal Women

    Miki Sakazaki (Mitsui DM Sugar Co., Ltd, Waseda Univ., Japan)

    15:45-16:10

    Modulatory Effects of Exercise Intensity on Eating Inhibitory Control: Neuro-Visual Insights into Intensity-Dependent Food Cue Responses

    Min-Seong Ha (Univ. of Seoul, Korea)

    16:10-16:25

    Panel Discussion

    David M. O’Sullivan (Seoul Nat'l Univ., Korea)

    Jang Soo Yook (POSTECH, Korea)

  • 10:00-12:10

    APDO Rising Session

    Rising Stars in Metabolic Science: Emerging Mechanisms and Translational Insights
    will be updated.
    10:00-10:18

    From Variant to Mechanism: SLC22A3 Links Metformin Transport to Lipoprotein Metabolism and Adipose Biology

    Clarie Wang (The Univ. of Auckland, New Zealand)

    10:18-10:36

    Tracing Central Carbon Flux in Liver: Amino Acid Is the Major Fuel for Hepatic Lipogenesis

    Yilie Liao (Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China)

    10:36-10:54

    Adaptive Expansion of Adipose Tissue Reservoir Capacity Improves Insulin Sensitivity

    Joon Ho Moon (Seoul Nat'l Univ., Korea)

    10:54-11:12

    Discovery of the ACLY Inhibitor 326E and Its Potential Therapeutic Applications for MASH and Hypercholesterolemia

    Zhifu Xie (Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China)

    11:12-11:30

    Exercise-Driven Musculoskeletal Alteration and Health

    Hyeonwoo Kim (KAIST, Korea)

    11:30-11:48

    The Genetic Impact on Diabetes and Its Complications

    Ken Suzuki (The Univ. of Tokyo, Japan)

    11:48-12:06

    Context-Dependent Regulation of Brown Adipose Tissue Thermogenesis

    Su Myung Jung (Sungkyunkwan Univ., Korea)

  • 13:15-15:30

    APDO Session 1

    Novel Therapeutic Strategies and Organ Crosstalk in Metabolic Disease
    will be updated.
    13:15-13:40

    Role of Cellular Senescence in MASH

    Yong-ho Lee (Yonsei Univ., Korea)

    13:40-14:05

    A Pulsatile FXR Agonist Designed as A First-in-Class Treatment for Bile Acid-Related Liver Diseases

    Jia Li (Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China)

    14:05-14:30

    Targeting Gut Microbiota–Host Crosstalk to Control Obesity

    Shiho Fujisaka (Univ. of Toyama, Japan)

    14:30-14:55

    Muscle Mass Regulation and Metabolic Control

    Wataru Ogawa (Kobe Univ., Japan)

    14:55-15:20

    From Target Discovery to Therapeutics: Advancing New Treatment Paradigms for Metabolic Disease

    Feng Xu (Hengrui Singapore R&D Centre, Singapore)

  • 15:45-17:50

    APDO Session 2

    Molecular and Cellular Regulators of Obesity and Metabolic Homeostasis
    will be updated.
    15:45-16:10

    Endotrophin as a Key Matrikine that Drives the Fibroinflammatory Niche in Chronic Liver Disease and Beyond

    Jiyoung Park (UNIST, Korea)

    16:10-16:35

    Beyond Inflammation: Emerging Regulatory Roles of Adipose Tissue Dendritic Cells in Obesity and Metabolic Homeostasis

    Kae Won Cho (SIMS, Korea)

    16:35-17:00

    Action-Machinery of Adiponectin for Organ Protection via T-Cadherin

    Iichiro Shimomura (The Univ. of Osaka, Japan)

    17:00-17:25

    The Mechanosensor Piezo1 Balances Bone Marrow Adipogenesis and Bone Formation via a Mechanoinflammatory Loop

    Baile Wang (The Univ. of Hong Kong, Hong Kong)

    17:25-17:50

    A Liver-Derived Factor SerpinA1 Activates Brown Adipose Tissue and Maintains Energy Expenditure to Prevent Obesity and Diabetes

    Masaji Sakaguchi (Kumamoto Univ., Japan)

  • 10:00-12:10

    APDO Rising Session

    Rising Stars in Metabolic Science: Emerging Mechanisms and Translational Insights
    will be updated.
    10:00-10:18

    From Variant to Mechanism: SLC22A3 Links Metformin Transport to Lipoprotein Metabolism and Adipose Biology

    Clarie Wang (The Univ. of Auckland, New Zealand)

    10:18-10:36

    Tracing Central Carbon Flux in Liver: Amino Acid Is the Major Fuel for Hepatic Lipogenesis

    Yilie Liao (Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China)

    10:36-10:54

    Adaptive Expansion of Adipose Tissue Reservoir Capacity Improves Insulin Sensitivity

    Joon Ho Moon (Seoul Nat'l Univ., Korea)

    10:54-11:12

    Discovery of the ACLY Inhibitor 326E and Its Potential Therapeutic Applications for MASH and Hypercholesterolemia

    Zhifu Xie (Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China)

    11:12-11:30

    Exercise-Driven Musculoskeletal Alteration and Health

    Hyeonwoo Kim (KAIST, Korea)

    11:30-11:48

    The Genetic Impact on Diabetes and Its Complications

    Ken Suzuki (The Univ. of Tokyo, Japan)

    11:48-12:06

    Context-Dependent Regulation of Brown Adipose Tissue Thermogenesis

    Su Myung Jung (Sungkyunkwan Univ., Korea)

  • 13:15-15:30

    APDO Session 1

    Novel Therapeutic Strategies and Organ Crosstalk in Metabolic Disease
    will be updated.
    13:15-13:40

    Role of Cellular Senescence in MASH

    Yong-ho Lee (Yonsei Univ., Korea)

    13:40-14:05

    A Pulsatile FXR Agonist Designed as A First-in-Class Treatment for Bile Acid-Related Liver Diseases

    Jia Li (Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China)

    14:05-14:30

    Targeting Gut Microbiota–Host Crosstalk to Control Obesity

    Shiho Fujisaka (Univ. of Toyama, Japan)

    14:30-14:55

    Muscle Mass Regulation and Metabolic Control

    Wataru Ogawa (Kobe Univ., Japan)

    14:55-15:20

    From Target Discovery to Therapeutics: Advancing New Treatment Paradigms for Metabolic Disease

    Feng Xu (Hengrui Singapore R&D Centre, Singapore)

  • 15:45-17:50

    APDO Session 2

    Molecular and Cellular Regulators of Obesity and Metabolic Homeostasis
    will be updated.
    15:45-16:10

    Endotrophin as a Key Matrikine that Drives the Fibroinflammatory Niche in Chronic Liver Disease and Beyond

    Jiyoung Park (UNIST, Korea)

    16:10-16:35

    Beyond Inflammation: Emerging Regulatory Roles of Adipose Tissue Dendritic Cells in Obesity and Metabolic Homeostasis

    Kae Won Cho (SIMS, Korea)

    16:35-17:00

    Action-Machinery of Adiponectin for Organ Protection via T-Cadherin

    Iichiro Shimomura (The Univ. of Osaka, Japan)

    17:00-17:25

    The Mechanosensor Piezo1 Balances Bone Marrow Adipogenesis and Bone Formation via a Mechanoinflammatory Loop

    Baile Wang (The Univ. of Hong Kong, Hong Kong)

    17:25-17:50

    A Liver-Derived Factor SerpinA1 Activates Brown Adipose Tissue and Maintains Energy Expenditure to Prevent Obesity and Diabetes

    Masaji Sakaguchi (Kumamoto Univ., Japan)

  • 08:00-09:00

    Breakfast Symposium 1

    will be updated.
    08:00-08:30

  • 09:00-10:30

    Joint Symposium 1 (KSSO-TOS)

    Obesity and Women's Health Across the Lifespan: From Fertility to Frailty
    will be updated.
    09:00-09:25

    09:25-09:50

    09:50-10:15

    10:15-10:30 Panel Discussion
  • 10:45-10:55

    Opening Address

    10:45-10:55

    Opening Address

  • 10:55-11:35

    Keynote Lecture

    10:55-11:25

    Toward Precision Medicine Based on Clinical Trials and Real-World Data in Japan

    Kohjiro Ueki (Nat’l Institute of Global Health and Medicine, Japan Institute for Health Security, Japan)

    11:25-11:35

    Q&A

  • 11:35-12:15

    Plenary Lecture 1

    11:35-12:05

    Adipose Tissue Plasticity in Health and Disease at Single Cell Resolution

    Susanne Mandrup (Univ. of Southern Denmark, Denmark)

    12:05-12:15

    Q&A

  • 12:30-13:15

    Luncheon Symposium 1

    will be updated.
    12:30-12:50

    12:50-13:10

  • 14:15-15:45

    Symposium 5

    Is Surgery Still Relevant? Debatable Indications for MBS in the Era of GLP-1 Therapies
    14:15-14:40

    Redefining Referral Pathways in the GLP-1RA Era

    Ki Bum Park (The Catholic Univ. of Korea, Korea)

    14:40-15:05

    Adolescents with Severe Obesity: Should We Operate Earlier?

    Su Min Ahn (Yonsei Univ., Korea)

    15:05-15:30

    Elderly Patients: Too Risky or Underutilized?

    Ming-Che Hsin (China Medical Univ., Taiwan)

    15:30-15:45

    Panel Discussion

  • 16:00-16:40

    Plenary Lecture 2

    16:00-16:30

    Metabolic Heterogeneity of Obesity

    Samuel Klein (Washington Univ., USA)

    16:30-16:40

    Q&A

  • 16:55-18:25

    Joint Symposium 3 (KSSO-EASO)

    Management of CVD and Cardiometabolic Risk Factors in Obesity
    16:55-17:20

    Obesity and Heart Failure

    Kyung-Hee Kim (Incheon Sejong Hosp., Korea)

    17:20-17:45

    Obesity and Lipid Disorders: Residual Cardiovascular Risk and Emerging Therapies

    Yu Mi Kang (Harvard Medical School, USA)

    17:45-18:10

    18:10-18:25

    Panel Discussion

  • 18:25-19:25

    Satellite Symposium 2

    will be updated.
    18:25-18:55

    18:55-19:20

  • 08:00-09:00

    Breakfast Symposium 2

    will be updated.
    08:00-08:30

  • 09:00-10:30

    Symposium 2

    Beyond Incretins: Diversifying the Therapeutic Landscape for Obesity
    09:00-09:25

    From Incretin-Targeting to Multi-Hormonal Approaches: The Role of Amylin and Glucagon

    Timothy Garvey (Univ. of Alabama at Birmingham, USA)

    09:25-09:50

    Neural, Peripheral, and Alternative Pathways in Obesity

    Yoo-Bin Seo (Konkuk Univ., Korea)

    09:50-10:15

    Novel Therapeutics for Muscle Health: In the Context of Obesity and More

    Haemin Chon (Hanmi Pharm. Co., Ltd., Korea)

    10:15-10:30

    Panel Discussion

    Boyeon Kim (Soon Chun Hyang Univ., Korea)

    Bumjo Oh (Seoul Nat'l Univ., Korea)

  • 10:45-10:55

    Opening Address

    10:45-10:55

    Opening Address

  • 10:50-11:30

    Keynote Lecture

    10:55-11:25

    Toward Precision Medicine Based on Clinical Trials and Real-World Data in Japan

    Kohjiro Ueki (Nat’l Institute of Global Health and Medicine, Japan Institute for Health Security, Japan)

    11:25-11:35

    Q&A

  • 11:35-12:15

    Plenary Lecture 1

    11:35-12:05

    Adipose Tissue Plasticity in Health and Disease at Single Cell Resolution

    Susanne Mandrup (Univ. of Southern Denmark, Denmark)

    12:05-12:15

    Q&A

  • 12:30-13:15

    Luncheon Symposium 1

    will be updated.
    12:30-12:50

    12:50-13:10

  • 14:15-15:45

    Symposium 6

    Rethinking Exercise in Obesity Management: Efficacy, Fitness, and the Power of Exercise Snacks
    14:15-14:40

    Exercise as a Polypill in Cancer: Beyond Metabolism-Inflammation, Rehabilitation, and Survival

    Yong Kwan Jeon (Yonsei Univ., Korea)

    14:40-15:05

    Cardiorespiratory Fitness: An Underappreciated Modulator of Obesity-Related Cardiometabolic Risk and Mortality

    Sae Young Jae (Univ. of Seoul, Korea)

    15:05-15:30

    Exercise Snacks for Fitness and Health: Physiological Basis and Practical Application

    Martin Gibala (McMaster Univ., Canada)

    15:30-15:45

    Panel Discussion

    Kyung Hee Park (Hallym Univ., Korea)

    SoJung Lee (Kyung Hee Univ., Korea)

  • 16:00-16:40

    Plenary Lecture 2

    16:00-16:30

    Metabolic Heterogeneity of Obesity

    Samuel Klein (Washington Univ., USA)

    16:30-16:40

    Q&A

  • 16:55-18:25

    Symposium 11

    Beyond Calories: Diet Quality and Nutrient Composition in Obesity
    16:55-17:20

    Transitioning from Nutrient Ratios to Nutrient Density and Real Food in the 2025-2030 DGA

    Teresa Fung (Simmons Univ., USA)

    17:20-17:45

    Translating the 2025 KDRIs into Action: Food-Based Strategies for Improving Dietary Quality

    YoonJu Song (The Catholic Univ. of Korea, Korea)

    17:45-18:10

    The Evolution of Chinese Dietary Guidelines and Strategic Responses to the Rapidly Increasing Obesity Epidemic

    Liwang Gao (Capital Medical Univ., China)

    18:10-18:25

    Panel Discussion

    SuJin Song (Hannam Univ., Korea)

    Jean Kyung Paik (Eulji Univ., Korea)

  • 18:25-19:25

    Satellite Symposium 3

    will be updated.
    18:25-18:55

    18:55-19:20

  • 08:00-09:00

    Breakfast Symposium 3

    will be updated.
    08:00-08:30

  • 09:00-10:30

    Symposium 3

    Neural Circuits in Energy Homeostasis and Eating Behavior
    09:00-09:30

    TBD

    Wei Shen (ShanghaiTech Univ., China)

    09:30-10:00

    The Neurobiology of Overeating (2025 Neuron)

    Christian Lüscher (Univ. of Geneva, Switzerland)

    10:00-10:30

    TBD

    Ja-Hyun Baik (Korea Univ., Korea)

  • 10:45-10:55

    Opening Address

    10:45-10:55

    Opening Address

  • 10:55-11:35

    Keynote Lecture

    10:55-11:25

    Toward Precision Medicine Based on Clinical Trials and Real-World Data in Japan

    Kohjiro Ueki (Nat’l Institute of Global Health and Medicine, Japan Institute for Health Security, Japan)

    11:25-11:35

    Q&A

  • 11:35-12:15

    Plenary Lecture 1

    11:35-12:05

    Adipose Tissue Plasticity in Health and Disease at Single Cell Resolution

    Susanne Mandrup (Univ. of Southern Denmark, Denmark)

    12:05-12:15

    Q&A

  • 12:30-13:15

    Luncheon Symposium 2

    will be updated.
    12:30-12:50

    12:50-13:10

  • 14:15-15:45

    Symposium 7

    Lipid Metabolism and Atherosclerosis in Obesity
    14:15-14:40

    Understanding Atherogenic Dyslipidemia in Obesity

    Brian Tomlinson (Macau Univ. of Science and Technology, Macau, China)

    14:40-15:05

    Managing Obesity-Related Dyslipidemia in Real-World Practice

    Bom Taeck Kim (Ajou Univ., Korea)

    15:05-15:30

    Beyond Weight Loss: Current and Future Strategies for Lipid Remodeling and Dyslipidemia

    Eun-Jung Rhee (Sungkyunkwan Univ., Korea)

    15:30-15:45

    Panel Discussion

    Yoo-Bin Seo (Konkuk Univ., Korea)

    Hyun Ah Kim (Veterans Health Service Medical Center, Korea)

  • 16:00-16:40

    Plenary Lecture 2

    16:00-16:30

    Metabolic Heterogeneity of Obesity

    Samuel Klein (Washington Univ., USA)

    16:30-16:40

    Q&A

  • 16:55-18:25

    Symposium 12

    Central and Peripheral Coordination of Energy and Glucose Homeostasis
    16:55-17:25

    Role of GIP on the Regulation of Energy Homeostasis

    Daisuke Yabe (Kyoto Univ., Japan)

    17:25-17:55

    Central Role of GLP-1 in Regulating Energy Homeostasis

    Zhiping Pang (Rutgers Univ., USA)

    17:55-18:25

    2026 Nat Commun - Hypothalamic Regulation of Intestinal Glucose Absorption

    Se Hee Min (Univ. of Ulsan, Korea)

  • 18:25-19:25

    Satellite Symposium 4

    will be updated.
    18:25-18:55

    18:55-19:20

  • 08:50-10:30

    APDO Session 3

    Precision and Systems Medicine Approaches in Metabolic Disorders & Obesity
    08:50-09:15

    National Team Program on Genomic Precision Medicine for Metabolic Disease

    Peter Shepherd (Univ. of Auckland, New Zealand)

    09:15-09:40

    Discovery of Metabolic Regulators in Disease Treatment

    Weiping Han (Institute of Molecular and Cell Biology, A*STAR, Singapore)

    09:40-10:05

    Defective BCAA Metabolism Drives Macrophage Inflammation and Beta Cell Dysfunction in Obesity and Its Related Diabetes

    Kenneth Cheng (The Hong Kong Polytechnic Univ., Hong Kong, China)

    10:05-10:30

    Metabolic Throttling through ER–Mitochondria Decoupling

    XingXing Kong (Fudan Univ., China)

  • 13:15-14:15

    Oral Presentation 1

    will be updated.
  • 14:10-15:50

    APDO Session 4

    Adipose Tissue Dynamics and Metabolic Remodeling
    14:10-14:35

    Finding Key Drivers for Obesity Related Metabolic Dysfunction in Human Visceral Adipose Tissue

    Sung Hee Choi (Seoul Nat'l Univ., Korea)

    14:35-15:00

    Mechanisms of Lipid Remodeling and Futile Cycling in Adipose Tissue

    Yun-Hee Lee (Seoul Nat'l Univ., Korea)

    15:00-15:25

    How Do Dietary Lipids Reshape the Gut Mucus Niche to Drive Dysbiosis and Metabolic Dysfunction?

    Cen Xie (Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China)

    15:25-15:50

    Synergism Between GLP-1 and FGF21 in Counteracting Obesity-Related Metabolic Complications

    Aimin Xu (Univ. of Hong Kong, Hong Kong)

  • 16:50-18:20

    APDO Session 5

    Muscle-Adipose Interactions and Metabolic Pathways in Aging and Disease
    16:50-17:20

    Exploration of the Mechanism by Which Sarcopenia Promotes Cardiovascular Disease

    Kohjiro Ueki (Nat'l Institute of Global Health and Medicine, Japan Institute for Health Security, Japan)

    17:20-17:50

    Beyond Organ Size Control: YAP/TAZ Link Adipocyte State to Systemic Physiology

    Jae Myoung Suh (KAIST, Korea)

    17:50-18:20

    Adipose Plasticity and Metabolism

    Jae Bum Kim (Seoul Nat'l Univ., Korea)

  • 08:50-10:30

    APDO Session 3

    Precision and Systems Medicine Approaches in Metabolic Disorders & Obesity
    08:50-09:15

    National Team Program on Genomic Precision Medicine for Metabolic Disease

    Peter Shepherd (Univ. of Auckland, New Zealand)

    09:15-09:40

    Discovery of Metabolic Regulators in Disease Treatment

    Weiping Han (Institute of Molecular and Cell Biology, A*STAR, Singapore)

    09:40-10:05

    Defective BCAA Metabolism Drives Macrophage Inflammation and Beta Cell Dysfunction in Obesity and Its Related Diabetes

    Kenneth Cheng (The Hong Kong Polytechnic Univ., Hong Kong, China)

    10:05-10:30

    Metabolic Throttling through ER–Mitochondria Decoupling

    XingXing Kong (Fudan Univ., China)

  • 13:15-14:15

    Oral Presentation 2

    will be updated.
  • 14:10-15:50

    APDO Session 4

    Adipose Tissue Dynamics and Metabolic Remodeling
    14:10-14:35

    Finding Key Drivers for Obesity Related Metabolic Dysfunction in Human Visceral Adipose Tissue

    Sung Hee Choi (Seoul Nat'l Univ., Korea)

    14:35-15:00

    Mechanisms of Lipid Remodeling and Futile Cycling in Adipose Tissue

    Yun-Hee Lee (Seoul Nat'l Univ., Korea)

    15:00-15:25

    How Do Dietary Lipids Reshape the Gut Mucus Niche to Drive Dysbiosis and Metabolic Dysfunction?

    Cen Xie (Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China)

    15:25-15:50

    Synergism Between GLP-1 and FGF21 in Counteracting Obesity-Related Metabolic Complications

    Aimin Xu (Univ. of Hong Kong, Hong Kong)

  • 16:50-18:20

    APDO Session 5

    Muscle-Adipose Interactions and Metabolic Pathways in Aging and Disease
    16:50-17:20

    Exploration of the Mechanism by Which Sarcopenia Promotes Cardiovascular Disease

    Kohjiro Ueki (Nat'l Institute of Global Health and Medicine, Japan Institute for Health Security, Japan)

    17:20-17:50

    Beyond Organ Size Control: YAP/TAZ Link Adipocyte State to Systemic Physiology

    Jae Myoung Suh (KAIST, Korea)

    17:50-18:20

    Adipose Plasticity and Metabolism

    Jae Bum Kim (Seoul Nat'l Univ., Korea)

  • 14:00-15:30

    Symposium 8 (K)

    The Missing Piece in Incretin-Based Anti-Obesity Therapies: Real-World, Case-Driven Nutrition Care Strategies
    14:00-14:25

    Getting It Right from the Start: Comprehensive Nutritional Assessment in Patients on Anti-Obesity Medications

    YeonHee Lee (Ajou Univ. Hosp., Korea)

    14:25-14:50

    Nutrition that Keeps Treatment Going: Managing Side Effects that Threaten Intake and Muscle

    Ahreum Shin (Seoul Nat'l Univ. Bundang Hosp., Korea)

    14:50-15:15

    Keeping the Weight Off: Navigating Weight Regain After Anti-Obesity Medications

    Minjee Han (Soonchunhyang Univ. Hosp. Cheonan, Korea)

    15:15-15:30

    Panel Discussion

    So Young Kim (Nat'l Cancer Center, Korea)

    Mihyang Kim (Ajou Univ. Hosp., Korea)

  • 16:55-18:25

    Symposium 13

    Hidden Barriers to Obesity Care
    16:55-17:20

    Evidence and Risk of Intentional Fasting for Weight Loss

    Isabel Krug (The Univ. of Melbourne, Australia)

    17:20-17:45

    Food Insecurity and Obesity: The Social Context of Weight and Health

    Seo Young Kang (Eulji Univ., Korea)

    17:45-18:10

    Beyond Willpower: Psychological and Behavioral Barriers to Obesity Care

    Chung-Ying Lin (Nat'l Cheng Kung Univ., Taiwan)

    18:10-18:25

    Panel Discussion

    Youn Huh (The Catholic Univ. of Korea, Korea)

    Sujin Kim (Korea Univ., Korea)

  • 13:15-14:15

    Guided Poster Presentation 1

    will be updated.
  • 13:15-14:15

    Guided Poster Presentation 2

    will be updated.
  • 13:15-14:15

    Guided Poster Presentation 3

    will be updated.
  • 13:15-14:15

    Guided Poster Presentation 4

    will be updated.
  • 08:00-09:00

    Breakfast Symposium 4

    will be updated.
    08:00-08:30

  • 09:00-10:30

    Symposium 4

    Transforming Obesity and Diabetes Care through AI and Digital Health Care
    will be updated.
    09:00-09:30

    TBD

    Sang Youl Rhee (Kyung Hee Univ., Korea)

    09:30-10:00

    CGM as a Digital Biomarker — Shaping the Future of Diabetes Care

    Sun Joon Moon (Sungkyunkwan Univ., Korea)

    10:00-10:30

    Digital Health and AI in Metabolic Diseases: From Innovation to Implementation

    Sunjae Lee (KAIST, Korea)

  • 12:30-13:15

    Luncheon Symposium 3

    will be updated.
    12:30-12:50

    12:50-13:10

  • 14:15-15:45

    Symposium 9

    Real-World Challenges in Obesity Treatment
    14:15-14:40

    The Non-Responder: Boosting Efficacy with Behavioral and Lifestyle Strategies

    Sangho Shin (Konyang Univ., Korea)

    14:40-15:05

    Balancing Efficacy and Safety: Dealing with Adverse Effects

    Yang-Hyun Kim (Korea Univ., Korea)

    15:05-15:30

    The Yo-Yo Problem: Tackling Weight Regain

    Zhen An (The Univ. of Melbourne, Australia)

    15:30-15:45

    Panel Discussion

  • 09:00-10:30

    Joint Symposium 2 (KSSO-JASSO)

    Pediatric Obesity in East Asia: From Clinical Care to Lifestyle and Community Approaches
    will be updated.
    09:00-09:20

    Pediatric Obesity in Japan: Current Landscape, Policy, and Practice

    Satomi Koyama (Dokkyo Medical Univ., Japan)

    09:20-09:40

    Diagnostic Criteria for Pediatric Obesity Disease in Japan and a Novel School-Based Screening System for Lifestyle-Related Diseases

    Mitsuhiko Hara (Wayo Women's Univ., Japan)

    09:40-10:00

    Community-Based Life-Course Nutrition Support and Health Promotion in Korea: Current Status and Perspectives from the Seoul Experience

    Ji-Yun Hwang (Sangmyung Univ., Korea)

    10:00-10:20

    Moving Toward Healthier Futures: Physical Activity and Pediatric Obesity in East Asia from the Global Matrix Initiative

    Eun-Young Lee (Yonsei Univ., Korea)

    10:20-10:30 Q&A
  • 14:15-15:45

    Symposium 10

    Multidisciplinary Management of Obesity: Brain, Ovary, and Airway
    14:15-14:40

    Obesity and Brain Aging: Can Weight Management Reduce Dementia Risk?

    Keun You Kim (Yonsei Univ., Korea)

    14:40-15:05

    Obesity and PCOS: Beyond Menstrual Irregularity to Fertility and Metabolic Health

    Jin Ju Kim (Seoul Nat'l Univ., Korea)

    15:05-15:30

    Obesity Management in Obstructive Sleep Apnea: Integrating Weight-Loss Strategies into CPAP-Based Care

    Sookyoung Park (Chungnam Nat'l Univ., Korea)

    15:30-15:45

    Panel Discussion

    Jin-Woo Jung (Wonkwang Univ., Korea)

    Yoon Jeong Cho (Daegu Catholic Univ., Korea)

  • 08:00-09:00

    Breakfast Symposium 5

    will be updated.
    08:00-08:30

  • 09:00-10:30

    Symposium 14

    Recent Update in Oral Anti-Obesity Drugs: Who Will be the Winner?
    09:00-09:25

    Cumulative Effect of Obesity Phenotypes on Body Weight and Body Mass Index

    Andres J. Acosta (Mayo Clinic, USA)

    09:25-09:50

    The Role and Position of Oral GIP/GLP-1

    Jun Hwa Hong (Eulji Univ., Korea)

    09:50-10:15

    Oral Semaglutide: Anti-Obesity Efficacy and CV Outcome

    Timothy Garvey (Univ. of Alabama at Birmingham, USA)

    10:15-10:30

    Panel Discussion

  • 10:40-11:20

    Plenary Lecture 3

    10:40-11:10

    TBD

    Jennifer L. Baker (Copenhagen Univ., Denmark)

    11:10-11:20

    Q&A

  • 11:20-12:00

    Presidential Lecture

    11:20-11:50

    TBD

    TBD

    11:50-12:00

    Q&A

  • 12:10-13:10

    Luncheon Symposium 4

    will be updated.
    12:10-12:30

    12:30-12:50

  • 14:10-14:50

    Plenary Lecture 4

    14:10-14:40

    Anti-Obesity Treatment in GLP1 Era

    Julio Rosenstock (Univ. of Texas Southwestern Medical Center, USA)

    14:40-14:50

    Q&A

  • 15:00-16:30

    Symposium 19

    Real-World Evidence of GLP-1–Based Therapies
    15:00-15:25

    GLP-1 Therapy in Lower-BMI Patients: Real-World Evidence from Korea

    Hae-Jin Ko (Kyungpook Nat'l Univ., Korea)

    15:25-15:50

    GLP-1-Based Obesity Therapy in Japan: Real World Challenges

    Wataru Ogawa (Kobe Univ., Japan)

    15:50-16:15

    Mitigating Muscle Loss in the Era of GLP-1 Therapy: Strategies and Emerging Combination Approaches

    Yun Kyung Cho (Univ. of Ulsan, Korea)

    16:15-16:30

    Panel Discussion

    Ga Eun Nam (Korea Univ., Korea)

    Boyeon Kim (Soon Chun Hyang Univ., Korea)

    Jong Han Choi (Konkuk Univ., Korea)

  • 16:40-17:00

    Closing & Award Ceremony

    16:40-17:00

    Closing Address

  • 08:00-09:00

    Breakfast Symposium 6

    will be updated.
    08:00-08:30

  • 09:00-10:30

    Symposium 15

    Beyond Weight Loss: Nutrition Care Strategies for Patients on Incretin-Based Anti-Obesity Therapies
    09:00-09:25

    How Obesity Medications Drive Body Composition Changes through Appetite Suppression and Metabolic Regulation

    Jae Hyun Bae (Seoul Nat'l Univ., Korea)

    09:25-09:50

    Nutrition Risk Assessment During GLP-1 Receptor Agonist Therapy: Practical Screening Strategies for Clinical Practice

    Marie Spreckley (Univ. of Cambridge, UK)

    09:50-10:15

    The GLP-1 Effect: Understanding Consumer Behavior Shifts and Their Impact on Food, Nutrition and Innovation

    Shinok Park (Noom Korea, Korea)

    10:15-10:30

    Panel Discussion

    Meera Kweon (Seoul Nat'l Univ. Hosp., Korea)

    Yeo Jin Hong (Korea Univ. Ansan Hosp., Korea)

  • 10:40-11:20

    Plenary Lecture 3

    10:40-11:10

    TBD

    Jennifer L. Baker (Copenhagen Univ., Denmark)

    11:10-11:20

    Q&A

  • 11:20-12:00

    Presidential Lecture

    11:20-11:50

    TBD

    TBD

    11:50-12:00

    Q&A

  • 12:10-13:10

    Luncheon Symposium 5

    will be updated.
    12:10-12:30

    12:30-12:50

  • 14:10-14:50

    Plenary Lecture 4

    14:10-14:40

    Anti-Obesity Treatment in GLP1 Era

    Julio Rosenstock (Univ. of Texas Southwestern Medical Center, USA)

    14:40-14:50

    Q&A

  • 15:00-16:30

    Symposium 20

    Understanding Puzzle of Mechanistic Action
    15:00-15:25

    Glucagon and Hepatic Steatosis

    Naim Alkhouri (Summit Clinical Research, USA)

    15:25-15:50

    Deep Dive to GIP with Metabolic Disease

    Daisuke Yabe (Kyoto Univ., Japan)

    15:50-16:15

    TBD

    Martin Haluzik (Diabetes Centre, Institute for Clinical and Experimental Medicine, Czech)

    16:15-16:30

    Panel Discussion

  • 16:40-17:00

    Closing & Award Ceremony

    16:40-17:00

    Closing Address

  • 08:00-09:00

    Breakfast Symposium 7

    will be updated.
    08:00-08:30

  • 09:00-10:30

    Symposium 16

    Organellar Dysfunction in Obesity and Related Diseases
    09:00-09:30

    Plasmalogens as Emerging Regulators of Metabolic Homeostasis: From Hepatic Steatosis to Adipose Immunometabolism

    Eun Hee Koh (Univ. of Ulsan, Korea)

    09:30-10:00

    An Oxysterol-Binding Protein Regulates Lipid Homeostasis Across Metabolic Tissues in Zebrafish

    Seong-Kyu Choe (Wonkwang Univ., Korea)

    10:00-10:30

    Endocrine Roles of Circulating N-Acetylaspartate

    Sean M. Hartig (Baylor College of Medicine, USA)

  • 10:40-11:20

    Plenary Lecture 3

    10:40-11:10

    TBD

    Jennifer L. Baker (Copenhagen Univ., Denmark)

    11:10-11:20

    Q&A

  • 11:20-12:00

    Presidential Lecture

    11:20-11:50

    TBD

    TBD

    11:50-12:00

    Q&A

  • 12:10-13:10

    Luncheon Symposium 6

    will be updated.
    12:10-12:30

    12:30-12:50

  • 14:10-14:50

    Plenary Lecture 4

    14:10-14:40

    Anti-Obesity Treatment in GLP1 Era

    Julio Rosenstock (Univ. of Texas Southwestern Medical Center, USA)

    14:40-14:50

    Q&A

  • 15:00-16:30

    Symposium 21

    Metabolic Rewiring in Obesity-Related Diseases
    15:00-15:35

    Harnessing the Power of Proteomics to Reinvent Cardiometabolic Disease Research

    Sasha A. Singh (Harvard Medical School, USA)

    15:35-16:10

    Nutritional Interventions Driving Hepatic Metabolic Reprogramming

    Hoon-Ki Sung ( Univ. of Toronto, Canada)

    16:10-16:30

    Targeting Mitochondria to Rejuvenate Metabolic & Renal Diseases

    Jae-Han Jeon (Kyungpook Nat'l Univ., Korea)

  • 09:00-10:30

    Symposium 17 (K)

    Highly-Cited Papaers in TOP Journals in the Field of Endocrinology and Metabolism in Korea
    will be updated.
    09:00-09:25

    Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017

    Eugene Han (Keimyung Univ., Korea)

    09:25-09:50

    Ultra-Processed Food Consumption and Obesity: A Narrative Review of Their Association and Potential Mechanisms

    Jee-Seon Shim (Yonsei Univ., Korea)

    09:50-10:15

    Lipid Variability Induces Endothelial Dysfunction by Increasing Inflammation and Oxidative Stress 

    Seung-Hwan Lee (The Catholic Univ. of Korea, Korea)

    10:15-10:30

    Panel Discussion

    Chang Hee Jung (Univ. of Ulsan, Korea)

    Ga Eun Nam (Korea Univ., Korea)

  • 09:00-10:30

    Symposium 18

    Building Effective School Health Screening Systems for Pediatric Obesity
    will be updated.
    09:00-09:25

    Current Landscape of Pediatric Obesity in Korea: Insights from School Health Screening

    Jaehyun Kim (The Catholic Univ. of Korea, Korea)

    09:25-09:50

    Student Health Surveillance and Public Health Strategies for Pediatric Obesity in Hong Kong

    Wing Shan Queenie See (The Univ. of Hong Kong, Hong Kong, China)

    09:50-10:15

    Advancing the Korean School Health Screening System: Future Directions and Challenges

    Haryeom Ghang (Nat'l Health Insurance Service, Korea)

    10:15-10:30

    Panel Discussion

    Jung-Soo Choi (Gangdong Public Health Center, Korea)

    Yong Hyuk Kim (Yonsei Univ. Wonju, Korea)

  • 15:00-16:30

    Co-Medical Session (K)

    Do We Need Certified Obesity Educators in Korea?
    will be updated.
    15:00-15:25

    The Need for Certified Obesity Educators

    Yang-Hyun Kim (Korea Univ., Korea)

    15:25-15:50

    Current Status of Obesity Education in Korean Medical Centers

    Yeonjeong Jang (Severance Hosp., Korea)

    15:50-16:15

    Current Status of Nutrition Education for Obesity Management

    Jung Joo Lee (Yongin Severance Hosp., Korea)

    16:15-16:30

    Panel Discussion

    Young Na (Yeouido St. Mary’s Hosp., Korea)

    Jeong Hyun Lim (Seoul Nat'l Univ. Hosp., Korea)

    Sang Yong Kim (Chosun Univ., Korea)

  • 13:10-14:10

    Guided Poster Presentation

    will be updated.